AUA2023 has come and gone, returning to the Windy City for the first time since 2019. Once again, urologists from all over the nation and the world came to teach and share their latest innovations, discoveries, and evidence-based insights at the largest annual meeting of urologists and urological professionals. Whether you came away from the events with a fresh perspective on single-port robotic-assisted procedures or a fresh pair of sperm-emblazoned socks, new techniques and vendors were everywhere you looked.

In case you missed the latest conference, or just couldn’t be everywhere you wanted to be at once, there’s still time to watch most of the weekend’s big events, with AUA2023 On Demand. Plenary sessions, forums, specialty societies, abstract sessions, satellite symposia, and more are available online through August 31 (https://www.auadailynews.org/meeting-coverage/article/22861070/aua2023-on-demand).

But if you’re too busy placing difficult Foleys, or only have 5 minutes between cases today, here’s a recap of some of the biggest highlights from the weekend.

There’s a Flurry of New Guidelines

Prostate cancer screening guidelines have been updated to include a baseline PSA test for men ages 45 to 49, or age 40 to 45 for those at increased risk. The evidence supporting the safety of transperineal biopsy has strengthened, and there was even a lively discussion over renaming grade group 1 disease to drop the term “carcinoma” to minimize overtreatment. Dedicated and updated upper tract urothelial carcinoma guidelines have arrived, including recommendations for intravesical chemotherapy after ureteroscopic biopsy and screening for Lynch syndrome in upper tract urothelial carcinoma patients, which affects ∼10% of this patient population.

Is Percutaneous Nephrolithotomy Dead?

Depends on who you ask. Advancements in mini and ultra-mini percutaneous nephrolithotomy have made careful patient selection and surgeon experience critical factors in deciding who would benefit from the latest advancements in making the treatment of large stones even more minimally invasive.

New Evidence May Change How You Practice

If you listened to Dr Shore, you might be convinced that enzalutamide in combination with leuprolide may become the new standard of care for patients with high-risk biochemical recurrence, based on the EMBARK trial.

Front and Center in Pediatrics: Ethics, Diversity, and Inclusion

The shock waves from the Dobbs decision are still being felt, raising questions about the future of fetal intervention, and the evolving discussions surrounding gender-affirming care have extended to and impacted the work of pediatric urologists across the country. Caring for patients across state lines is a particularly vexing challenge in the current climate.

Lastly, there was a renewed focus on the health of… urologists. Presentations on ergonomics to reduce injuries, studies on the value of microbreaks and stretching in the operating room for reduction of pain, and sessions on combating burnout to maximize well-being and career longevity were among the most popular on the #AUA2023 Twitterverse.

A huge thank you is owed to the thousands of staff, speakers, vendors, participants, presenters, and volunteers who helped make AUA2023 a tremendous success.

See you next year in San Antonio!

Since its inception in 2002, the Residents and Fellows Committee has represented the voice of trainee members of the AUA. The Committee’s mission is to address the educational and professional needs of urology residents and fellows, and promote engagement between residents and fellows and the AUA. The Committee welcomes your input and feedback! To contact the Committee, or to inquire about ways to get more involved, please email rescommittee@AUAnet.org.